Recent

% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • biotechpicklist biotechpicklist May 7, 2014 8:17 AM Flag

    Amarantus News This morning!

    "Amarantus and Brewer Sports Announce 3rd #C4CT Concussion Awareness Summit Focused on TBI-Induced Alzheimer's"

    3rd #C4CT Summit to be Held on Thursday, July 31 at the United Nations, NY
    GlobeNewswire Amarantus BioScience Holdings, Inc.
    7 minutes ago
    MINNEAPOLIS, Minn., SAN FRANCISCO and GENEVA, SWITZERLAND, May 7, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus Bioscience Holdings, Inc. (AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to cell cycle dysregulation, endoplasmic reticulum stress, neurodegeneration and apoptosis, have announced their 3rd #C4CT (Coalition for Concussion Treatment) Concussion Awareness Summit, on Thursday, July 31, 2014 at the United Nations in New York City, NY.

    "As we prepare to launch our blood diagnostic LymPro Test (R) for Alzheimer's disease in the second half of 2014, we believe it is critical to identify populations who are at the highest risk of developing Alzheimer's disease so that we may conduct clinical research to identify common pathways among those who progress to Alzheimer's disease," said Gerald E. Commissiong, President & CEO of Amarantus. "Traumatic Brain Injury is a clear risk factor that we believe accelerates an already-present predisposition for Alzheimer's disease. Current and former athletes and soldiers who have been exposed to multiple concussions and sub-concussive events should be on high alert for symptomatology of early Alzheimer's disease."

    The 3rd #C4CT Summit will focus on important scientific, medical translational and prevention-related topics of Traumatic Brain Injury (TBI) and the link to Alzheimer's disease and Parkinson's disease. The summit will bring together high-level executives and business leaders, renowned researchers, international diplomats, major media outlets and professional athletes to discuss a variety of topics surrounding TBI induced Alzheimer's and other neurodegenerative diseases on a global platform.

    "The recent advances in concussion research and treatment have been more substantial than any other time in history. Being able to link these findings not only to protect athletes but to all those suffering from neurodegenerative diseases such as Alzheimer's across the globe is a huge step forward for the #C4CT campaign," explains H.E. Ambassador Jack Brewer, CEO of BSI.

    Sentiment: Strong Buy

 
AMBS
2.10-0.07(-3.23%)Sep 2 4:05 PMEDT